Financial Ratios

INDOCO REMEDIES LTD.

NSE : INDOCOBSE : 532612ISIN CODE : INE873D01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE328.50-6.05 (-1.81 %)
PREV CLOSE ( ) 334.55
OPEN PRICE ( ) 335.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6666
TODAY'S LOW / HIGH ( )327.00 338.25
52 WK LOW / HIGH ( )307 416.95
NSE328.65-5.25 (-1.57 %)
PREV CLOSE( ) 333.90
OPEN PRICE ( ) 337.85
BID PRICE (QTY) 328.65 (268)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 75404
TODAY'S LOW / HIGH( ) 327.45 338.80
52 WK LOW / HIGH ( )306.4 415
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)15.3416.7710.032.63-0.31
   CEPS(Rs)23.0025.3417.9610.327.46
   DPS(Rs)2.252.251.500.300.30
   Book NAV/Share(Rs)111.3898.1383.4473.8171.74
   Tax Rate(%)26.2234.5929.6615.5469.26
Margin Ratios
   Core EBITDA Margin(%)17.0921.1717.5510.947.93
   EBIT Margin(%)13.0116.4712.384.971.22
   Pre Tax Margin(%)11.5015.3410.592.60-0.96
   PAT Margin (%)8.4810.047.452.19-0.29
   Cash Profit Margin (%)12.7215.1613.348.597.10
Performance Ratios
   ROA(%)8.5810.607.171.97-0.23
   ROE(%)14.6418.4712.753.62-0.43
   ROCE(%)17.4223.3115.595.791.24
   Asset Turnover(x)1.011.060.960.900.79
   Sales/Fixed Asset(x)1.261.281.081.071.06
   Working Capital/Sales(x)4.394.455.8110.7810.61
Efficiency Ratios
   Fixed Capital/Sales(x)0.790.780.930.930.94
   Receivable days70.9462.8965.1566.6075.87
   Inventory Days69.7064.9965.6364.6271.02
   Payable days91.64100.02145.00186.13182.48
Valuation Parameters
   PER(x)21.2222.4628.7779.560.00
   PCE(x)14.1514.8616.0620.2927.18
   Price/Book(x)2.923.843.462.842.83
   Yield(%)0.690.600.520.140.15
   EV/Net Sales(x)1.982.402.341.952.20
   EV/Core EBITDA(x)11.4911.1112.8117.1225.51
   EV/EBIT(x)15.2314.5718.9139.18179.62
   EV/CE(x)1.932.342.171.741.74
   M Cap / Sales1.802.252.141.741.93
Growth Ratio
   Net Sales Growth(%)8.2524.1412.1414.29-6.79
   Core EBITDA Growth(%)-13.5746.7380.2450.78-40.27
   EBIT Growth(%)-14.5165.18179.41363.91-83.53
   PAT Growth(%)-8.5267.25281.03953.48-106.90
   EPS Growth(%)-8.5267.25281.02953.52-106.90
Financial Stability Ratios
   Total Debt/Equity(x)0.310.270.340.380.45
   Current Ratio(x)1.891.671.521.221.20
   Quick Ratio(x)1.131.070.940.770.79
   Interest Cover(x)8.5814.556.912.090.56
   Total Debt/Mcap(x)0.100.070.100.140.16

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.